Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells

被引:63
作者
Wang, Jaw-Yuan [1 ,2 ,3 ,4 ,5 ]
Chen, Ben-Kuen [9 ]
Wang, Yu-Shiuan [1 ]
Tsai, Yao-Ting [1 ]
Chen, Wei-Chiao [1 ]
Chang, Wen-Chang [6 ,7 ]
Hou, Ming-Feng [3 ]
Wu, Yang-Chang [8 ,10 ,11 ]
Chang, Wei-Chiao [1 ,3 ,12 ]
机构
[1] Kaohsiung Med Univ, Dept Med Genet, Coll Med, 100 TzYou 1st Rd, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ Hosp, Div Gastrointestinal & Gen Surg, Coll Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Ctr Canc, Coll Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Dept Surg, Coll Med, Kaohsiung 807, Taiwan
[5] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan
[6] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan
[7] Taipei Med Univ, Coll Med, Taipei, Taiwan
[8] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan
[9] Natl Cheng Kung Univ, Inst Bioinforrnat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan
[10] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan
[11] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan
[12] Kaohsiung Med Univ, Ctr Resources Res & Dev, Kaohsiung 807, Taiwan
关键词
ORAI1/CRACM1; STIM1; Store-operated calcium channel; EGF; Cyclooxygenase-2; GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; COLON-CANCER; CYCLOOXYGENASE-2; EXPRESSION; MUTATION STATUS; KRAS MUTATIONS; CETUXIMAB; INHIBITION; OVEREXPRESSION; RISK;
D O I
10.1016/j.cellsig.2011.08.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Growing evidence shows that chronic inflammation drives the progression of colorectal cancer (CRC). Cyclooxygenase-2 (COX-2) is one of the most important inflammatory genes involved in solid tumor metastasis. Epidermal growth factor receptor (EGFR) also plays a key role in cancer cell development. We compared the expression levels of EGFR and COX-2 between tumor and normal tissues from 20 CRC patients and studied the molecular mechanism of EGFR-mediated COX-2 gene expression in cancer cells. Our results indicated that COX-2 expression was markedly increased after EGF stimulation. COX-2 promoter analysis indicated the involvement of cyclic AMP-responsive element (CRE) and nuclear factor of activated T cells/nuclear factor interleukin-6 (NFAT/NF-IL6)-binding sites in EGF-mediated signaling pathways. Furthermore, EGF-mediated COX-2 activation was prevented by 2-aminoethoxydiphenyl borate (2-APB), a store-operated Ca2+ channel inhibitor. Transfection of siRNA against ORAI1 or STIM1, the key regulators of store-operated Ca2+ channels, showed significant inhibitory effects on EGF-mediated COX-2 expression. In conclusion, store-operated Ca2+ entry is involved in the activation of transcription factors (CREB/NFAT) that are responsible for delivering EGF-mediated signals to evoke inflammatory cascades and is eventually related to CRC tumorigenesis. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 48 条
[1]   EGFR, HER-2 and COX-2 levels in colorectal cancer [J].
Antonacopoulou, A. G. ;
Tsamandas, A. C. ;
Petsas, T. ;
Liava, A. ;
Scopa, C. D. ;
Papavassiliou, A. G. ;
Kalofonos, H. P. .
HISTOPATHOLOGY, 2008, 53 (06) :698-706
[2]   Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets? [J].
Bergmann, Frank ;
Moldenhauer, Gerhard ;
Herpel, Esther ;
Gaida, Matthias M. ;
Strobel, Oliver ;
Werner, Jens ;
Esposito, Irene ;
Mueerkoester, Susanne Sebens ;
Schirmacher, Peter ;
Kern, Michael A. .
HISTOPATHOLOGY, 2010, 56 (04) :440-448
[3]  
Cheng J, 2002, CANCER RES, V62, P4157
[4]   Induction of cyclooxygenase-2 by bovine type I collagen in macrophages via C/EBP and CREB activation by multiple cell signaling pathways [J].
Cho, MK ;
Cho, YH ;
Lee, GH ;
Kim, SG .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (12) :2239-2250
[5]   Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-β binding via a common signaling pathway [J].
Cieslik, K ;
Zhu, Y ;
Wu, KK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49304-49310
[6]   COX-2 and the cyclopentenone prostaglandins - a new chapter in the book of inflammation? [J].
Colville-Nash, PR ;
Gilroy, DW .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 62 (01) :33-43
[7]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[8]   KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab [J].
De Roock, W. ;
Piessevaux, H. ;
De Schutter, J. ;
Janssens, M. ;
De Hertogh, G. ;
Personeni, N. ;
Biesmans, B. ;
Van Laethem, J. -L. ;
Peeters, M. ;
Humblet, Y. ;
Van Cutsem, E. ;
Tejpar, S. .
ANNALS OF ONCOLOGY, 2008, 19 (03) :508-515
[9]   Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy [J].
Di Fiore, F. ;
Blanchard, F. ;
Charbonnier, F. ;
Le Pessot, F. ;
Lamy, A. ;
Galais, M. P. ;
Bastit, L. ;
Killian, A. ;
Sesboue, R. ;
Tuech, J. J. ;
Queuniet, A. M. ;
Paillot, B. ;
Sabourin, J. C. ;
Michot, F. ;
Michel, P. ;
Frebourg, T. .
BRITISH JOURNAL OF CANCER, 2007, 96 (08) :1166-1169
[10]   Peptide growth factors in the intestine [J].
Dignass, AU ;
Sturm, A .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (07) :763-770